Secukinumab is effective in a patient on haemodialysis for end-stage renal disease and severe hidradenitis suppurativa

J Eur Acad Dermatol Venereol. 2024 Feb 20. doi: 10.1111/jdv.19868. Online ahead of print.

Authors

Nessr Abu Rached^{1

2}, Lennart Ocker^{1

2}, Eggert Stockfleth^{1

2}, Falk G Bechara^{1

2}

Affiliations

¹ Department of Dermatology, Venereology and Allergology, International Centre for Hidradenitis Suppurativa/Acne Inversa (ICH), Ruhr-University Bochum, Bochum, Germany.
² Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.

PMID: 38376098
DOI: 10.1111/jdv.19868

No abstract available

Publication types

Letter